Advertisements

Brufen GEL

Quick links to important sections

Brufen GEL

Advertisements
Advertisements

Treatment option:

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Advertisements

Overview of Brufen GEL

What is Brufen GEL? Defining the Localized Anti-Inflammatory Agent

Property Description
Active ingredient Flurbiprofen (INN)
Form Topical Gel (for external use)
Pharmacological class Non-Steroidal Anti-Inflammatory Drug (NSAID)
Common purpose To provide localized relief from pain and inflammation
Origin Synthetic (Propionic Acid Derivative)

Brufen GEL is a synthetic pharmaceutical preparation intended for external use, classified as a Non-Steroidal Anti-Inflammatory Drug (NSAID). Its primary component is the active ingredient Flurbiprofen (INN), which belongs to the class of Propionic Acid Derivatives. This classification as an NSAID defines the medicine’s core identity, indicating that it functions by influencing the body’s mechanisms for generating inflammation and pain signals. The specific presentation of Brufen GEL is commonly recognized for its use in adults seeking localized relief for mild discomfort associated with strained soft tissues.


Composition, Form, and General Purpose

The medicine is supplied as a Topical Gel and is a single-ingredient product designed to deliver Flurbiprofen through the skin surface. This dosage form utilizes a suitable base, often a hydroalcoholic gel, for external application. The general purpose of Brufen GEL is to provide localized anti-inflammatory and analgesic relief directly where it is applied.

Flurbiprofen acts as an inhibitor of prostaglandin synthesis. This action is pharmacologically supported as the mechanism that reduces the local production of chemical messengers like prostaglandins that initiate swelling and tenderness in tissues, directly addressing the underlying source of discomfort.


Topical vs. Systemic NSAIDs: The Localized Approach

The choice of the topical gel form is a strategic feature that differentiates it from oral NSAID tablets by focusing the medicinal effect on a specific area. This distinction is key: instead of being fully absorbed into the bloodstream to circulate systemically, the gel is formulated to allow localized absorption of the Flurbiprofen into the underlying soft tissues. This approach aims to maximize the concentration of the anti-inflammatory agent at the site of discomfort, offering a focused pathway to relief while minimizing systemic exposure compared to orally administered NSAIDs. The gel format, being non-greasy and rapidly absorbed, is often favored for convenient application to large areas of the skin.

Advertisements

What side effects are possible with Brufen GEL?

Possible Side Effects and Safety Information

The safety profile of Flurbiprofen Topical Gel is officially documented and categorized according to the frequency and type of adverse reactions observed. Due to its topical application, the profile is predominantly characterized by effects on the Skin and Subcutaneous Tissue Disorders.

Frequency and Systemic Classification

Adverse reactions classified as Common (may affect up to 1 in 10 people) are typically localized reactions at the application site. These include pruritus (itching), erythema (redness), rash, and various forms of dermatitis, consistent with the gel's function. The potential for systemic effects involving the Gastrointestinal or Nervous System Disorders is documented in regulatory sources but classified as Uncommon or Rare due to the low absorption rate.


Serious Adverse Reactions and Restrictions

Although rare with topical use, the potential for serious adverse reactions associated with the NSAID class is documented. These include severe systemic hypersensitivity reactions (e.g., bronchospasm) and severe bullous skin reactions such as Stevens-Johnson Syndrome. Photosensitivity reactions may occur upon exposure to sunlight or UV radiation.

Several high-level restrictions are noted in regulatory labels. Flurbiprofen gel is contraindicated in individuals with a history of hypersensitivity reactions to NSAIDs (including asthma or urticaria) and during the third trimester of pregnancy. Caution is specifically advised in populations such as older adults and patients with pre-existing renal impairment or hepatic failure, reflecting regulatory caution regarding systemic NSAID exposure.

Advertisements

Overdose and Emergency Response

Overdose of Flurbiprofen, the active ingredient in Brufen GEL, may result in systemic effects documented in regulatory sources, typically following accidental ingestion or excessive topical absorption. Documented clinical manifestations include common symptoms such as nausea, vomiting, stomach pain, abdominal pain, drowsiness, dizziness, headache, and tremor. Other presentations listed in official documents may include somnolence and tinnitus (ringing in the ears).

Overdose has the potential to lead to severe and life-threatening clinical outcomes. These serious manifestations include massive gastrointestinal bleeding, ulceration, or perforation, and acute renal failure. Neurological complications listed in official documents are seizures and coma (loss of consciousness).

In the event of suspected overdose, individuals must seek immediate medical attention. Emergency services (e.g., 911) must be contacted immediately if the individual has collapsed, had a seizure, has trouble breathing, or cannot be awakened. Regulatory documents confirm that no specific antidote is known for Flurbiprofen overdose, and management is restricted to symptomatic and supportive treatment and monitoring.

Advertisements

Therapeutic Uses of Brufen GEL

Brufen GEL is a topical non-steroidal anti-inflammatory drug (NSAID) used to provide localized anti-inflammatory and analgesic support directly to the affected area. This is considered relevant in clinical settings marked by the heightened symptoms of local tissue damage or inflammatory states. The core purpose of topical NSAIDs is relevant for easing pain and inflammation in conditions where functional stability becomes affected.

It is commonly used across conditions presenting with acute episodes and recurrent manifestations, including sprains, strains, bruises (contusions), muscle aches, and localized discomfort associated with osteoarthritis or tendinitis. This topical approach offers symptomatic support where symptoms have led to temporary functional strain.

“This application assists with maintaining functional stability and provides supportive relief when symptoms interfere with routine activities.”

Quick Fact: Relief for Localized Musculoskeletal Discomfort

Management and Benefits

Brufen GEL is commonly used for acute symptomatic episodes such as injuries from physical activity. It may assist with managing symptom clusters that include localized pain, tenderness, and swelling, helping to improve day-to-day comfort during symptomatic periods. The gel is also relevant for managing conditions marked by episodic or fluctuating symptom patterns. It may offer supportive relief, which is applicable when symptoms cluster into patterns requiring additional management of discomfort directly at the site of inflammation, and is applied in addressing pronounced inflammatory manifestations.

Regulatory References

  1. https://northeast.devonformularyguidance.nhs.uk/formulary/chapters/10-musculoskeletal-joint-diseases/10-1-rheumatic-diseases-and-gout/10-1-1-nsaids
Advertisements

Eligibility and Restrictions for Use

Official Eligibility Profile for Brufen GEL

Regulatory documents define strict eligibility criteria for the use of topical ibuprofen gel, ensuring its application is limited to appropriate populations. This information is based on official government regulatory sources and should be observed without exception.

Classification Eligibility Status
Use Allowed Adults and adolescents aged 12 years and over (with certain caveats for the elderly).
Contraindicated Individuals with known hypersensitivity to ibuprofen or other NSAIDs (like aspirin).
Contraindicated Women who are more than 6 months pregnant (third trimester).
Not Recommended Children under 12 years of age or women who are breastfeeding.

Additional Eligibility Restrictions

Brufen GEL must not be used on broken, damaged, infected, or diseased skin, or on mucous membranes (eyes, mouth, etc.). Use requires special caution in patients with a history of asthma, gastrointestinal problems (ulcers/bleeding), or existing renal or hepatic impairment, despite the low systemic absorption from the topical route. The gel is for external use only.

Advertisements

What should I know about interactions with other medicines?

The official interaction profile for Brufen GEL, which contains the NSAID Flurbiprofen, is documented by government health authorities and mandates specific restrictions due to the potential for systemic effects.

Mandatory Restrictions and Combinations to Avoid

The concurrent use of Brufen GEL with other Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), including cyclooxygenase-2 selective inhibitors, is officially avoided due to the potential for additive gastrointestinal adverse effects. Co-administration with analgesic doses of Acetylsalicylic Acid (Aspirin) is not generally recommended. A mandatory separation period applies to Mifepristone; Flurbiprofen should not be used for 8–12 days after its administration. Official documents also advise avoiding the co-application of other topical medications on the same area of skin.

Interactions Altering Risk and Exposure

Co-administration with Anticoagulants (e.g., Warfarin) may enhance their effects, officially increasing the risk of bleeding. This risk is also documented when combined with Oral Corticosteroids, Anti-platelet agents, or Selective Serotonin Reuptake Inhibitors (SSRIs). Alcohol is noted in regulatory sources as a substance that may increase the risk of adverse reactions, particularly gastrointestinal bleeding.

Effects on Drug Levels and Physiology

Brufen GEL may interfere with the intended function of Diuretics and Antihypertensive Drugs, officially reducing their effects. It is documented that NSAIDs can decrease the elimination of Lithium and Methotrexate, which may result in increased plasma levels of these substances. A population-specific caution exists: co-administration with ACE Inhibitors or Angiotensin II Antagonists may result in the deterioration of renal function, which is particularly relevant for the elderly or patients with compromised renal function.

Advertisements

Mechanism of Action

The active substance, ibuprofen, is an organic acid delivered via topical application, leading to its accumulation in underlying soft tissues and joint structures. It functions as a non-selective, reversible inhibitor of the cyclooxygenase (COX) enzyme isoforms, specifically COX-1 and COX-2.

This interaction directly impedes the molecular conversion of arachidonic acid to prostaglandin H2 ( PGH2) by both isoforms. The inhibition of PGH2 synthesis blocks the downstream cascade of prostanoid generation, including prostaglandins ( PGE2, PGI2) and thromboxane ( TxA2).

Consequentially, the concentration of these lipid signaling molecules is reduced at the targeted tissue site. This molecular intervention modulates the physiological processes mediated by prostanoids, such as local vasodilation, capillary permeability, and thermal regulation.

Advertisements

Dosage and Administration Information

How to Use Brufen GEL: Official Administration Guidelines

Brufen GEL (Flurbiprofen) is a topical medication whose administration follows established protocols for localized Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), emphasizing targeted use and minimal duration.

Administration Protocol

The approved route of administration is topical (external use only), for application to the intact skin surface. The dosing for the gel is typically measured by the physical quantity applied, such as a 2 g to 4 g mass (or a defined ribbon length) that is sufficient to cover the localized area of concern. The frequency is generally 2 to 4 times per day, with applications spaced appropriately over the day.

Administration Scope Official Instruction
Route of administration Topical, to the intact cutaneous surface.
Dosing frequency 2 to 4 times per day.
Administration rule Gently rub the gel into the skin until absorbed. Wash hands immediately after use (unless treating hands).
Duration limitation Use the lowest effective dose for the shortest duration necessary; treatment should generally not exceed 7 to 14 days without re-evaluation.
Age-group rule Not recommended for use in children under 12 years of age.

Procedural Summary

The protocol requires the gel to be applied to the affected area, ensuring it is rubbed in completely. The patient is instructed to avoid contact with broken skin, eyes, or mucous membranes. External heat or airtight occlusive dressings must not be applied to the treated area. These procedures ensure the medication is used strictly according to the localized administration method.

Advertisements

Recent Clinical Evidence

Brufen GEL: Recent Clinical Evidence

Evidence for Musculoskeletal Conditions

Research exploring topical Flurbiprofen (the active ingredient in Brufen GEL) has focused on studies involving conditions associated with short-term soft tissue trauma (such as sprains) and localized discomfort from chronic conditions like osteoarthritis. The evidence base here largely consists of Systematic Reviews and meta-analyses that aggregate data from controlled studies across the topical NSAID therapeutic class. Researchers monitored outcomes related to patient-reported physical discomfort and changes in daily functioning or activity level.

In these studies, findings describe patterns observed in the tested populations. Trials documented measured differences in outcomes related to symptom intensity over short-term intervals. The evidence for the topical NSAID class contributes to a High level classification; however, this classification applies to the class as a whole.

Supporting Research on Drug Penetration

To provide context on the physical characteristics of the topical gel in research, Pharmacokinetic (PK) trials using healthy adult subjects have been conducted. These studies monitored drug concentration achieved in the target soft tissues versus the systemic bloodstream. Data reported that the topical application was observed in trials to deliver a higher concentration measurement of the active ingredient to the deeper soft tissues. This research describes the measured concentration and distribution but does not provide data on clinical symptom change or patient response.

Research Gaps and Limitations

Clinical trials related to both acute and chronic localized pain primarily assess short-term outcomes. Follow-up durations were limited, and long-term effects are not fully established regarding sustained functional outcomes. Data for certain groups remain insufficient, as the majority of research has been observed in the general adult population. Research exploring the use of the topical gel in children was not included in the key regulatory trials. Furthermore, comparative evidence is lacking regarding the measured outcomes of this specific formulation against all other specific topical NSAID formulations.

Advertisements

Frequently Asked Questions (FAQ)

Common questions about Brufen GEL (FAQ)

Q: Is Brufen GEL considered a general painkiller or an anti-inflammatory treatment?

A: The active substance, Flurbiprofen, belongs to a class of medicines called Non-Steroidal Anti-Inflammatory Drugs (NSAIDs). This classification indicates that it possesses both anti-inflammatory properties, reducing swelling and redness, and analgesic (painkilling) properties. Official documents describe the medicine’s purpose as providing localized relief from both pain and inflammation.


Q: What immediate action is needed if Brufen GEL accidentally gets in the eyes?

A: Official product information advises users to avoid contact with the eyes, mouth, and other mucous membranes. If accidental contact does occur, the area should be immediately and thoroughly rinsed with clean, running water.


Q: Can using a larger amount of Brufen GEL than suggested increase the likelihood of side effects?

A: According to regulatory documents, the gel should be used at the lowest effective dose for the shortest time necessary. Using more than the recommended amount or applying the gel more often than instructed may increase the chance of experiencing unwanted effects, particularly systemic side effects from increased absorption.


Q: Are there any long-term or serious side effects associated with regular, prolonged use of the gel?

A: Clinical studies supporting the use of the topical gel primarily assessed short-term outcomes. For this reason, official guidance emphasizes that the medicine is intended for the shortest duration necessary, and the labeled duration of use generally does not extend beyond 7 to 14 days without the need for re-evaluation by a health professional.


Q: Can I use Brufen GEL on the same day that I am taking simple pain relief tablets?

A: Official guidance advises avoiding concurrent use of Brufen GEL with other NSAID medicines. When using non-NSAID pain relievers like paracetamol or acetaminophen, caution is still advised, and it is important to be aware of the total maximum recommended daily dosage for all medicines being used.


Q: Can older adults or elderly patients use Brufen GEL for pain relief?

A: The gel is generally allowed for use by older adults, but regulatory documents advise special caution for this population. This reflects a potentially higher risk of adverse reactions due to the way systemic NSAIDs are handled by the body, even with the low absorption from a topical product.


Q: Where on the body is it specifically advised to avoid applying Brufen GEL?

A: The official product information is explicit about areas to avoid. It is specified in regulatory documents that the gel is not to be applied to broken skin, wounds, skin that is damaged or infected, or any mucous membranes such as the inside of the mouth or nose.


Q: How should the application site look once the gel has been fully rubbed into the skin?

A: The administration rule is to gently rub the gel into the skin until it is completely absorbed. This formulation is designed to be non-greasy and rapidly absorbed, suggesting the application site will typically not have a visible layer, sticky feeling, or noticeable residue once rubbed in.


Q: Can I use a warm compress or an ice pack on the area treated with Brufen GEL?

A: According to official administration rules, the use of external heat or airtight occlusive dressings (like certain bandages) over the treated area is not permitted. This restriction is in place to prevent excessive systemic absorption. Regulatory documents do not typically place restrictions on the use of cold therapy, such as an ice pack.


Q: Can you explain the term 'non-steroidal anti-inflammatory' in easy-to-understand language?

A: A Non-Steroidal Anti-Inflammatory Drug, or NSAID, is a type of medicine that works by interfering with certain processes in the body that cause inflammation and pain. It does this by affecting the natural chemical messengers that are responsible for triggering swelling, tenderness, and pain signals.


Q: Is the use of Brufen GEL restricted by age or weight in official guidance?

A: Official product guidance includes restrictions based on age (not recommended for children under 12 years). However, the regulatory documents for this topical gel formulation do not specify restrictions based on the patient's body weight.


Q: Is Brufen GEL widely available to buy without needing a doctor's prescription?

A: The legal status of Brufen GEL—whether it is available only by prescription or as an over-the-counter (OTC) product—is determined by the regulatory authority in each specific country. Because these rules differ globally, its availability status can vary internationally.


Q: How long do the intended effects of Brufen GEL typically last after one application?

A: While an exact duration is not specified in patient labeling, the official maximum dosing schedule is up to four applications per day. This administration guideline suggests that the intended pain and inflammation relief effects of a single application are designed to last for several hours before the next application is permitted.


Q: What is the standard concentration of the active ingredient in Brufen GEL products?

A: Regulatory documents detailing the composition of the product indicate that the active ingredient, Flurbiprofen, is commonly found in a concentration of either 5% or 10% in commercially available topical gel formulations.


Q: Does Brufen GEL have a strong or unpleasant odor when applied?

A: The presence of a scent or odor is typically due to the non-active ingredients, or excipients, in the gel base. Some topical flurbiprofen products have been noted to have a transient, mild, or pleasant aromatic odor, rather than a strong or medicinal smell.


Q: Can Brufen GEL be used for pain relief in large joints like the knees or shoulders?

A: The product is indicated for pain and inflammation related to various musculoskeletal conditions. This includes localized discomfort from chronic conditions, such as that associated with osteoarthritis, which commonly affects large joints like the knees and shoulders.

Advertisements

How should Brufen GEL be stored and disposed of?

Storage and Disposal Requirements for Brufen Gel

Official labeling mandates specific conditions to maintain the stability and safety of Brufen Gel.


Storage Conditions

Requirement Description
Temperature Store below 25 C or 30 C, and do not freeze the product.
Protection Keep the tube in the outer carton to protect the gel from light.
Container Replace the cap tightly after each use to prevent drying.

Handling and Disposal

The medicine must be kept out of the sight and reach of children.

Disposal of any unused or expired product must be done in accordance with local regulatory requirements.

To protect the aquatic environment, the product must not be disposed of via wastewater (sinks or toilets).

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Brufen GEL found in:

A-Z Index: